Visalytics
Visalytics
approved EB-2 (NIW)

Research Scientist

Analytical Chemistry · Taiwan · 2025-04-26

Processing Time
552 days
Decision Date
2025-04-26
Location
Indiana
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop advanced bioanalytical chemistry techniques to improve molecular characterization and expedite the drug discovery process. His work focuses on investigating biological processes driving neurodegenerative disorders, metabolic diseases, and cancer to facilitate new therapies. Additionally, he aims to enhance quality control measures within pharmaceutical manufacturing.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses critical needs in biomedical science, specifically in understanding complex diseases and improving drug discovery.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 17 publications, 229 citations, and funding from NIH and Pfizer demonstrates his capacity to lead this research.

3 Balance of Factors Met

The petitioner's contributions to public health and scientific standards make it beneficial to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's publication of 17 peer-reviewed journal articles (9 as first author) and 229 citations. He also demonstrated professional standing through 11 peer reviews and secured funding from the National Institutes of Health (NIH), Pfizer, and the Ministry of Science and Technology. These metrics satisfied the Dhanasar criteria for national importance and being well-positioned.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Research Assistant

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
California 426 days 2025-01-08
The petitioner proposes to continue research in pharmaceutical chemistry with a focus on drug discovery optimization and the development of advanced computational techniques. This work involves identifying new therapeutics for human diseases and creating computational methods that offer significant advantages over conventional drug discovery approaches. The intended impact is to reduce the economic and social costs of disease while improving global public health.
View Case

Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) rfe approved
Illinois 367 days 2025-11-28
The petitioner proposes to use in-depth analysis of biological and chemical samples to advance the understanding of cellular reactions and mechanisms. Her work aims to devise biochemical and biomedical strategies to combat diseases and resolve urgent biomedical challenges, directly improving therapeutic development and public health outcomes.
View Case

Postdoctoral Researcher

Pharmaceuticals · Vietnam

WeGreened EB-2 (NIW) approved
278 days 2025-01-11
The petitioner proposes to identify and analyze novel bioactive compounds isolated from natural sources with distinct chemical diversity. This work aims to accelerate the development of new pharmaceuticals for chronic diseases that currently lack adequate treatments, such as diabetes, cardiovascular disease, and osteoporosis.
View Case

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
Wisconsin 94 days 2025-01-29
The petitioner proposes to investigate the design, synthesis, optimization, and characterization of small molecule compounds. This work focuses on developing therapeutic agents to address drug-resistant infections and improve medication safety and efficacy.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Research and Development cases More cases from Taiwan

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-26.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 552 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Taiwan All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist